Hansoh Pharma Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 9,643

Employees

  • Stock Symbol
  • 03692

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $4.32
  • (As of Monday Closing)

Hansoh Pharma General Information

Description

Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.

Contact Information

Website
www.hansoh.cn
Formerly Known As
Lianyungang Hansoh Pharmaceutical, Jiangsu Hansoh Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 9 Dongjin Road
  • Huaguoshan Avenue
  • Lianyungang, Jiangsu 222069
  • China
+86 0518
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Vertical(s)
Corporate Office
  • Number 9 Dongjin Road
  • Huaguoshan Avenue
  • Lianyungang, Jiangsu 222069
  • China
+86 0518

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hansoh Pharma Stock Performance

As of 16-Nov-2026, Hansoh Pharma’s stock price is $4.32. Its current market cap is $26.2B with 6.06B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.32 $4.39 $3.58 - $5.68 $26.2B 6.06B 10.9M $0.16

Hansoh Pharma Financials Summary

As of 30-Jun-2026, Hansoh Pharma has a trailing 12-month revenue of $2.27B.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 18,441,106 23,771,669 9,973,322 9,333,127
Revenue 2,272,110 2,089,787 1,708,715 1,428,124
EBITDA 1,027,048 815,697 626,853 465,621
Net Income 954,428 772,523 609,275 463,259
Total Assets 6,859,493 5,702,739 4,336,632 4,660,875
Total Debt 623,103 15,020 16,150 607,135
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hansoh Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hansoh Pharma‘s full profile, request access.

Request a free trial

Hansoh Pharma Patents

Hansoh Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026233408-A1 Polycyclic compounds, preparation methods and medicinal uses thereof Pending 09-May-2025
WO-2026233425-A1 Sirna, conjugate which contain sirna, pharmaceutical composition and uses thereof Pending 08-May-2025
WO-2026228738-A1 Tricyclic compound derivatives, preparation methods and medicinal uses thereof Pending 29-Apr-2025
WO-2026228633-A1 Antibody-drug conjugates and uses thereof Pending 28-Apr-2025
WO-2026228677-A1 Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereof Pending 28-Apr-2025
To view Hansoh Pharma’s complete patent history, request access »

Hansoh Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hansoh Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hansoh Pharma‘s full profile, request access.

Request a free trial

Hansoh Pharma Investments (2)

Hansoh Pharma’s most recent deal was a Early Stage VC with Blossom Bioscience for . The deal was made on 16-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Blossom Bioscience 16-Jun-2021 Early Stage VC Drug Discovery
Blossom Bioscience 10-May-2021 Joint Venture Drug Discovery
To view Hansoh Pharma’s complete investments history, request access »

Hansoh Pharma ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Hansoh Pharma’s complete esg history, request access »

Hansoh Pharma FAQs

  • When was Hansoh Pharma founded?

    Hansoh Pharma was founded in 1995.

  • Where is Hansoh Pharma headquartered?

    Hansoh Pharma is headquartered in Lianyungang, China.

  • What is the size of Hansoh Pharma?

    Hansoh Pharma has 9,643 total employees.

  • What industry is Hansoh Pharma in?

    Hansoh Pharma’s primary industry is Drug Discovery.

  • Is Hansoh Pharma a private or public company?

    Hansoh Pharma is a Public company.

  • What is Hansoh Pharma’s stock symbol?

    The ticker symbol for Hansoh Pharma is 03692.

  • What is the current stock price of Hansoh Pharma?

    As of 16-Nov-2026 the stock price of Hansoh Pharma is $4.32.

  • What is the current market cap of Hansoh Pharma?

    The current market capitalization of Hansoh Pharma is $26.2B.

  • What is Hansoh Pharma’s current revenue?

    The trailing twelve month revenue for Hansoh Pharma is $2.27B.

  • What is Hansoh Pharma’s annual earnings per share (EPS)?

    Hansoh Pharma’s EPS for 12 months was $0.16.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process